Science Explorer Back to mapMap
Discussion
Company · Louisville · United States

NX PharmaGen (United States)

nxpharmagen.comROR OpenAlex
Research works
2
fractional, all time
Citations
75
32.2 per fractional work
Top-10% rate
3.4%
all institutions 10.0%
Open access
89%
world 40%
International
36%
world 18%
NX PharmaGen (United States)

Not ranked overall: NX PharmaGen (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does NX PharmaGen (United States) work in?

In all years, 43% of research at NX PharmaGen (United States) is in Health Sciences, 30% in Physical Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (26%), Materials Science (17%).

Health Sciences: 1 fractional works · 43.5% of its workMedicine: 1 fractional works · 43.5% of its workPhysical Sciences: 1 fractional works · 30.4% of its workMaterials Science: 0 fractional works · 17.4% of its workEnvironmental Science: 0 fractional works · 8.7% of its workChemistry: 0 fractional works · 4.3% of its workLife Sciences: 1 fractional works · 26.1% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 26.1% of its workALL ITS WORKNX PharmaGen(United States)2fractional works, all years
Life Sciences26%Physical Sciences30%Health Sciences43%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine143.5%
    1. Materials Science017.4%
    2. Environmental Science08.7%
    3. Chemistry04.3%
    1. Biochemistry, Genetics and Molecular Biology126.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from NX PharmaGen (United States)?

The most cited paper from NX PharmaGen (United States) is "Gene cloning, sequence analysis, purification, and characterization of a thermostable aminoacylase from Bacillus stearothermophilus" (Vehary A. Sakanyan, L. Desmarez, Christianne Legrain et al., 1993), with 64 citations. Next come "Primary Structure, Partial Purification and Regulation of Key Enzymes of the Acetyl Cycle of Arginine Biosynthesis in Bacillus Stearothermophilus: Dual Function of Ornithine Acetyltransferase." (47) and "Use of atomic absorption spectroscopy in determining minerals in water" (0).

Most cited papers
#PaperReleasedCitations
1 Gene cloning, sequence analysis, purification, and characterization of a thermostable aminoacylase from Bacillus stearothermophilus Vehary A. Sakanyan, L. Desmarez, Christianne Legrain et al. · Applied and Environmental Microbiology Open access Nov 1993 64
2 Primary Structure, Partial Purification and Regulation of Key Enzymes of the Acetyl Cycle of Arginine Biosynthesis in Bacillus Stearothermophilus: Dual Function of Ornithine Acetyltransferase. Vehary A. Sakanyan, Daniël Charlier, Christianne Legrain et al. · Journal of General Microbiology Mar 1993 47
3 Use of atomic absorption spectroscopy in determining minerals in water Manushak Movsisyan, Shibli Sayeed, Nadezhda Movsisyan et al. · International Journal of Scientific Reports Open access 19 Feb 2026 0
4 16: Serum derived exosomes evaluated early in second trimester provide predictive biomarkers of risk for preterm birth before week 34 Alan M. Ezrin, Brian Brohman, Sarah A. Baxter et al. · American Journal of Obstetrics and Gynecology Open access 27 Dec 2012 0
All 4 most cited papers, with filters and sorting

Which research topics does NX PharmaGen (United States) publish most on?

By volume in 2022-now: Head and Neck Cancer Studies, Lung Cancer Research Studies, Heavy metals in environment and Analytical chemistry methods development.

Head and Neck Cancer Studies: 0 fractional worksLung Cancer Research Studies: 0 fractional worksHeavy metals in environment: 0 fractional worksAnalytical chemistry methods development: 0 fractional worksMine drainage and remediation techniques: 0 fractional worksCancer-related gene regulation: 0 fractional works
OtorhinolaryngologyOncologyPollutionAnalytical Chemistry2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Head and Neck Cancer Studies Otorhinolaryngology 0 works
  2. 2 Lung Cancer Research Studies Oncology 0 works
  3. 3 Heavy metals in environment Pollution 0 works
  4. 4 Analytical chemistry methods development Analytical Chemistry 0 works
  5. 5 Mine drainage and remediation techniques Environmental Chemistry 0 works
  6. 6 Cancer-related gene regulation Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available89.3%not open10.7%

World: 40% of research is openly available.

with international co-authors35.7%domestic only64.3%

World: 18% is written across borders.

How has NX PharmaGen (United States)'s research output changed?

still counting200020102020

Other research institutions in Louisville

All research institutions in Louisville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about NX PharmaGen (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.